|
rdfs:label
|
"Oksimetazolin"@id
"Oksimetazolin"@sh
"Oksimetazolin"@sr-el
"Oksimetazolin"@tr
"Oximetazolina"@es
"Oximetazolina"@it
"Oxymetazolin"@de
"ocsymetasolin"@cy
"oksimetazolin"@sl
"oksymetazolin"@nn
"oksymetazolina"@pl
"oximetazolin"@hu
"oximetazolina"@pt
"oxymetazoline"@en
"oxymetazoline"@nl
"oxymétazoline"@fr
"Оксиметазолин"@mk
"Оксиметазолин"@sr-ec
"оксиметазолин"@ru
"оксиметазолин"@sr
"оксиметазолін"@uk
"оксымэтазалін"@be-tarask
"אוקסימטזולין"@he
"أوكسي ميتازولين"@ar
"اوکسی متازولین"@azb
"اوکسی متازولین"@fa
"ଅକ୍ସିମେଟାଜୋଲିନ"@or
"オキシメタゾリン"@ja
"羟甲唑啉"@zh
"羟甲唑啉"@zh-hans
"羥甲唑啉"@zh-hant
|
|
skos:altLabel
|
"2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline"@en
"2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline"@cy
"2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline"@en
"3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol"@en
"3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol"@cy
"3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol"@en
"6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@en
"6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@en
"6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@cy
"6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@en
"6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@cy
"6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol"@en
"ATC kod R01AA05"@sr
"ATC kod S01GA04"@sr
"ATCvet kod QR01AB07"@sr
"Afrin"@en
"Afrin"@cy
"Afrin"@sr
"Afrin®"@cy
"Afrin®"@en
"C16H24N2O"@it
"Dristan"@sr
"Drixoral"@sr
"Iliadin"@sr
"Logicin"@sr
"Nafrine"@sr
"Nasivin"@sr
"Nasivine"@sr
"Nesivine"@nl
"Operil"@sl
"Oximetazolinum"@en
"Oxylazine"@sr
"Oxymetazolina"@en
"Oxymetazoline"@en
"Oxymetazolinhydrochlorid"@de
"Oxymetazolinum"@en
"Oxymethazoline"@en
"Oxymetozoline"@en
"Rhino humex"@nl
"Rhinofrenol"@sr
"Rhinolitan"@sr
"SCH-9384"@cy
"SCH-9384"@en
"Sinerol"@sr
"Vicks Sinex®"@cy
"Vicks Sinex®"@en
"Vicks sinex"@nl
"Visine L."@sr
"oxymethazoline"@cy
"oxymethazoline"@en
"Називин"@ru
"Назол"@ru
"Несопин"@ru
"Нокспрей"@ru
"Саноринчик"@ru
"אלרין"@he
|
|
schema:description
|
"Arzneistoff"@de
"a topical decongestant"@en
"cheemesch Verbindung"@lb
"cheemsch Verbinnen"@nds
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"médicament"@fr
"senyawa kimia"@id
"topikalni dekongestiv"@sl
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"хемиско соединение"@mk
"хімічна сполука"@uk
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ବନ୍ଦ ନାକ ଖୋଲିବା ପାଇଂ ଦିଆଯାଏ ।"@or
"രാസസംയുക്തം"@ml
|
|
schema:dateModified
|
"2026-11-04T14:12:13+00:00"^^xsd:dateTime
|
|
schema:version
|
2564716346
|
|
wikibase:identifiers
|
44
|
|
wikibase:sitelinks
|
26
|
|
wikibase:statements
|
74
|
|
p:P10245
|
wd:statement/Q417813-4396583e-4863-507c-0a6c-0c55ebcec099
|
|
wd:statement/Q417813-dd212043-47cc-68b1-b152-aab5abfe2376
|
|
p:P10283
|
wd:statement/Q417813-263F4731-9BE7-4E50-B6B9-F78FD747C15C
|
|
p:P11089
|
wd:statement/Q417813-5FF11832-39DE-4DEA-86BB-7C9B16073CE0
|
|
p:P11143
|
wd:statement/Q417813-B55A3B14-FF0B-49CB-A69F-8CDA0A7422F9
|
|
p:P11198
|
wd:statement/Q417813-21F5DEF3-FC16-43A8-98EB-60BC17230C2A
|
|
p:P11199
|
wd:statement/Q417813-46956C76-0032-43F7-8B96-B33F90563281
|
|
p:P117
|
wd:statement/Q417813-fe5c8b0b-4cb6-58b1-8baa-bc6d0a7edaab
|
|
p:P129
|
wd:statement/Q417813-2C244B8A-F1BF-40C6-AE61-54F6F10141D2
|
|
wd:statement/Q417813-3338DC5B-D448-4AAA-BF3E-733D35E1317D
|
|
wd:statement/Q417813-471C9FE8-05B5-4376-BC64-2722644C1DF0
|
|
wd:statement/Q417813-6449EA16-7872-4033-8067-B8E366C17E68
|
|
wd:statement/Q417813-65E2C1E2-6EDB-49DF-9E19-FBC4757E815C
|
|
wd:statement/Q417813-74524E7D-516F-4851-9FEA-EE05CA425074
|
|
wd:statement/Q417813-7B7599CF-E66E-4AEF-85C3-EAEC66870822
|
|
wd:statement/Q417813-E22A3567-94ED-44BF-9CDF-F80DE09EB4F7
|
|
wd:statement/Q417813-F2479454-9D4E-4697-922A-F5D4254E8EAF
|
|
p:P1579
|
wd:statement/Q417813-E3A69B9C-03F2-4200-954A-C986D62535A1
|
|
p:P2057
|
wd:statement/Q417813-2A5D7C0D-0FA1-4978-ADCF-7D517604A8A9
|
|
p:P2062
|
wd:statement/Q417813-3ED75C68-7EF6-4DC9-9255-2C93998B4ACF
|
|
p:P2067
|
wd:statement/Q417813-9DCEDAB8-F3F7-46F4-A7B6-A58F49384368
|
|
p:P2115
|
wd:statement/Q417813-396BF234-94E8-48DF-A799-D1F67F6265E4
|
|
p:P2175
|
wd:statement/Q417813-4D2DA8E7-3548-4533-9034-5244ECA9769A
|
|
wd:statement/Q417813-A5DE091E-CD7A-45BE-A0E7-144EA7FC14C4
|
|
wd:statement/Q417813-C98D295F-AAEC-4B35-94B3-F7999D9C570B
|
|
wd:statement/Q417813-E81EA270-8F85-4CB8-8D26-02ECC1577B2B
|
|
p:P2275
|
wd:statement/Q417813-8F038C65-8626-4635-9C61-C25C7F4C70EF
|
|
p:P231
|
wd:statement/Q417813-B94FA81B-70A2-4AE4-8392-77152A06846F
|
|
p:P232
|
wd:statement/Q417813-DC9ABCAC-6AA1-41F2-846C-9E504A6BA9A4
|
|
p:P233
|
wd:statement/Q417813-E76ECA1A-B294-4DD4-A9CF-DCC17CC5834A
|
|
p:P234
|
wd:statement/Q417813-6C3805BC-429F-4FA3-ADE5-90DCC16130BC
|
|
p:P235
|
wd:statement/Q417813-2EC3BFD5-CC0D-41AD-8042-4769517657F6
|
|
p:P2566
|
wd:statement/Q417813-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q417813-2A61AFF6-AD40-45B9-A585-26D9DD2BB86A
|
|
wd:statement/Q417813-31E5DE14-3AAC-4FBE-BE9E-6776AC3DFDEE
|
|
wd:statement/Q417813-5c2ef667-4eab-180a-18ba-f914df923f52
|
|
wd:statement/Q417813-AF660B58-D0E7-44FC-9894-D105B0D471D4
|
|
p:P274
|
wd:statement/Q417813-1DAE1CE4-9CBC-4111-86C1-EA4B458AFEBF
|
|
p:P279
|
wd:statement/Q417813-E5B9C22F-A5B6-49BC-B60A-3CBD07916D24
|
|
p:P2868
|
wd:statement/Q417813-3792DDF6-35BF-4131-A03B-20CE4A1350B9
|
|
wd:statement/Q417813-6B1C8E16-2907-4BCE-8956-0687532580B9
|
|
wd:statement/Q417813-96A56437-6049-4C55-A16F-069A56F47F91
|
|
p:P2877
|
wd:statement/Q417813-6ABE5E86-CF34-4C19-8C38-5C69F34A14AD
|
|
p:P2892
|
wd:statement/Q417813-4A98C243-E164-4185-A0FE-D2EBFB22B99A
|
|
p:P31
|
wd:statement/Q417813-99376C11-E253-49B5-8AB7-F48C2ED0F588
|
|
p:P3117
|
wd:statement/Q417813-7A7BBD6E-4E6E-46FC-B163-3F49AA88EE7D
|
|
p:P3345
|
wd:statement/Q417813-AA0921D1-B0F1-49FB-B007-7EC5DF1F8B6C
|
|
p:P3417
|
wd:statement/Q417813-479FBCC2-0E49-4E2D-9727-027B4D93FB35
|
|
p:P3636
|
wd:statement/Q417813-5B52E422-3EBA-4CEE-9E92-1B7016C6B13A
|
|
p:P366
|
wd:statement/Q417813-4F7685AA-DC69-4584-B790-39AFC6878765
|
|
p:P373
|
wd:statement/Q417813-D1625639-A491-4347-AAEA-7F841E614FCF
|
|
p:P3780
|
wd:statement/Q417813-20954E5F-58D0-49B1-BDCC-1F40DD7057D6
|
|
wd:statement/Q417813-bfad5890-46d3-aa82-0d20-2d7951632bab
|
|
p:P4250
|
wd:statement/Q417813-6A72A139-6804-4C4D-8684-CA707CF9F1C2
|
|
p:P486
|
wd:statement/Q417813-12749A99-E41A-40EF-B84C-90A662B95FFE
|
|
p:P5076
|
wd:statement/Q417813-F64FB1C0-E30D-42BF-838D-D50BB5791C30
|
|
p:P527
|
wd:statement/Q417813-AA166FE5-AAE2-4C37-91FF-673530C87111
|
|
wd:statement/Q417813-CFBFD187-1D4B-4F2F-BCAD-EB6DF1130DC6
|
|
p:P592
|
wd:statement/Q417813-43B94506-7B87-4CBA-BFEB-C121ED05FB4B
|
|
p:P595
|
wd:statement/Q417813-B5462FFB-915D-4C89-9F9C-337A2506CDDF
|
|
p:P6366
|
wd:statement/Q417813-64F6D9B8-08A4-4F39-8053-CC67ACC34B74
|
|
wd:statement/Q417813-F254F637-3F6B-46B7-9962-075B3A794F6F
|
|
p:P646
|
wd:statement/Q417813-A1F1E9BA-8034-4444-BF66-132016D4D743
|
|
p:P652
|
wd:statement/Q417813-3426C12F-0E95-4E22-8ED0-B20CBFF19823
|
|
p:P661
|
wd:statement/Q417813-6828BF3B-5F90-4561-A1B5-C793034BDDEC
|
|
p:P662
|
wd:statement/Q417813-62990574-823F-4DFA-8B57-2EBA34E5A902
|
|
p:P665
|
wd:statement/Q417813-143F21FB-6C3C-4BF4-A008-7C8228A5AC66
|
|
wd:statement/Q417813-D6833E09-D0DF-4A6C-B8A1-733D3700561F
|
|
p:P6694
|
wd:statement/Q417813-ea703f4c-47e1-c6dd-5429-d1d32fc212dc
|
|
p:P672
|
wd:statement/Q417813-2da31fdf-4b39-4a24-55ba-8d37684ca304
|
|
p:P683
|
wd:statement/Q417813-650C0887-B43F-4561-B0D7-1346B76DD315
|
|
p:P715
|
wd:statement/Q417813-C2B3093F-A4E6-4245-94B2-1441C70B8178
|
|
p:P8494
|
wd:statement/Q417813-E3361231-A6D5-4254-808C-1761CB5E38D3
|
|
p:P9272
|
wd:statement/Q417813-7ADF2AB2-D371-41D2-89B1-C2D1C6F7AA25
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000147584>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D010109>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL762>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2780042274>
|
|
<https://makg.org/entity/2780819523>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/4475>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4636>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/C07363>
|
|
<http://www.kegg.jp/entry/D08322>
|
|
p:direct-normalized/P6694
|
<http://id.nlm.nih.gov/mesh/M0015681>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D03.383.129.308.704>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_7862>
|
|
wdt:P10245
|
"a608026"
|
|
"a617018"
|
|
wdt:P10283
|
"C2780042274"
|
|
wdt:P11089
|
"614257"
|
|
wdt:P11143
|
"Oxymetazoline"
|
|
wdt:P11198
|
"2032"
|
|
wdt:P11199
|
"PD009632"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Oxymetazoline.svg>
|
|
wdt:P129
|
5-hydroxytryptamine receptor 2C
|
|
5-hydroxytryptamine receptor 1D
|
|
Adrenoceptor alpha 2B
|
|
5-hydroxytryptamine receptor 1B
|
|
Adrenoceptor alpha 1A
|
|
Adrenoceptor alpha 1B
|
|
Adrenoceptor alpha 1D
|
|
Adrenoceptor alpha 2C
|
|
Adrenoceptor alpha 2A
|
|
wdt:P1579
|
"886303"
|
|
wdt:P2057
|
"HMDB0015070"
|
|
wdt:P2062
|
"3143"
|
|
wdt:P2067
|
260.188863^^xsd:decimal
|
|
wdt:P2115
|
"N0000147584"
|
|
wdt:P2175
|
rhinitis
|
|
conjunctivitis
|
|
nasopharyngitis
|
|
rosacea
|
|
wdt:P2275
|
"oxymetazoline"@en
|
|
wdt:P231
|
"1491-59-4"
|
|
wdt:P232
|
"216-079-1"
|
|
wdt:P233
|
"CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C"
|
|
wdt:P234
|
"InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)"
|
|
wdt:P235
|
"WYWIFABBXFUGLM-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.014.618"
|
|
wdt:P267
|
"D11AX27"
|
|
"R01AA05"
|
|
"R01AB07"
|
|
"S01GA04"
|
|
wdt:P274
|
"C₁₆H₂₄N₂O"
|
|
wdt:P279
|
imidazoline
|
|
wdt:P2868
|
decongestant
|
|
alpha-adrenergic agonist
|
|
sympathomimetic drug
|
|
wdt:P2877
|
"24301"
|
|
wdt:P2892
|
"C0030071"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID3040691"
|
|
wdt:P3345
|
"7812"
|
|
wdt:P3417
|
"Oxymetazoline"
|
|
wdt:P3636
|
"J5C"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Oxymetazoline"
|
|
wdt:P3780
|
Rhofade
|
|
Vicks Sinex
|
|
wdt:P4250
|
0.4^^xsd:decimal
|
|
wdt:P486
|
"D010109"
|
|
wdt:P5076
|
"RD-15-01345"
|
|
wdt:P527
|
carbon
|
|
nitrogen
|
|
wdt:P592
|
"CHEMBL762"
|
|
wdt:P595
|
"124"
|
|
wdt:P6366
|
"2780042274"
|
|
"2780819523"
|
|
wdt:P646
|
"/m/058246"
|
|
wdt:P652
|
"8VLN5B44ZY"
|
|
wdt:P661
|
"4475"
|
|
wdt:P662
|
"4636"
|
|
wdt:P665
|
"C07363"
|
|
"D08322"
|
|
wdt:P6694
|
"M0015681"
|
|
wdt:P672
|
"D03.383.129.308.704"
|
|
wdt:P683
|
"7862"
|
|
wdt:P715
|
"DB00935"
|
|
wdt:P8494
|
"DTXCID1020691"
|
|
wdt:P9272
|
"10289"
|